Search
Subscribe Now
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Johnson & Johnson
Johnson & Johnson
Page 4 of 18
Health
J&J, Sputnik, and Sinopharm vaccines found to be largely ineffective in fighting Omicron: study
By
Bloomberg
December 17, 2021
Newsletters
Stocks and crypto falter, looking set to close out the week on a losing streak
By
Bernhard Warner
December 17, 2021
Health
CDC panel recommends Pfizer and Moderna vaccines over Johnson & Johnson
By
Lauran Neergaard
,
Mike Stobbe
and
The Associated Press
December 16, 2021
Health
As COVID deaths top 800,000, Omicron and Delta variants threaten another U.S. surge
By
Erika Fry
and
Nicolas Rapp
December 15, 2021
Health
Scientists recommend COVID booster shots after 4 studies show vaccines may be less effective against the Omicron variant
By
Sophie Mellor
December 8, 2021
Magazine
11 steady-rising stocks to own for 2022
By
Anne Sraders
December 1, 2021
Health
COVID infections are rising again as the Omicron variant emerges in nearly 20 countries
By
Erika Fry
and
Nicolas Rapp
November 30, 2021
Health
Global drugmakers could roll out Omicron-adapted COVID vaccines in 100 days
By
Yvonne Lau
November 29, 2021
Health
Johnson & Johnson turn to influencers for help in reaching Gen-Z shoppers
By
Riley Griffin
,
Kim Bhasin
and
Bloomberg
November 16, 2021
Health
Here are the side effects you can expect from a COVID-19 vaccine booster shot
By
Kylie Logan
November 16, 2021
Finance
Johnson & Johnson shares jump as company follows GE and Toshiba in decision to split business apart
By
Riley Griffin
,
John Lauerman
and
Bloomberg
November 12, 2021
Health
The U.S. administered more COVID shots this week than it has since spring
By
Nicolas Rapp
and
Erika Fry
November 10, 2021
Health
Nearly 20 months into the global pandemic, infections are again on the rise
By
Erika Fry
and
Nicolas Rapp
November 3, 2021
Health
Who is eligible for a Moderna booster?
By
Felicia Hou
October 22, 2021
Health
More people are getting boosters than first doses of COVID vaccines right now
By
Marco Quiroz-Gutierrez
October 21, 2021
Most Popular
AI
This CEO laid off nearly 80% of his staff because they refused to adopt AI fast enough. 2 years later, he says he'd do...
By
Nick Lichtenberg
Newsletters
The oil CEO who stood up to Trump is a follower of the disciplined 'Exxon way' and has a history of blunt statements
By
Jordan Blum
Banking
'Absolutely, positively no chance, no way, no how, for any reason': Dimon says he'd never run the Fed but 'would take...
By
Jacqueline Munis